AAAAAA

   
Results: 1-14 |
Results: 14
ABNORMALITIES DETECTED ON TRANSVAGINAL ULTRASONOGRAPHY IN TAMOXIFEN-TREATED POSTMENOPAUSAL BREAST-CANCER PATIENTS MAY REPRESENT ENDOMETRIALCYSTIC ATROPHY
Authors: MCGONIGLE KF SHAW SL VASILEV SA ODOMMARYON T ROY S SIMPSON JF
Citation: Kf. Mcgonigle et al., ABNORMALITIES DETECTED ON TRANSVAGINAL ULTRASONOGRAPHY IN TAMOXIFEN-TREATED POSTMENOPAUSAL BREAST-CANCER PATIENTS MAY REPRESENT ENDOMETRIALCYSTIC ATROPHY, American journal of obstetrics and gynecology, 178(6), 1998, pp. 1145-1150
SURGICAL-MANAGEMENT OF THYROID-CANCER INVADING THE AIRWAY
Authors: MCCARTY TM KUHN JA WILLIAMS WL ELLENHORN JDI OBRIEN JC PRESKITT JT LIEBERMAN ZH STEPHENS J ODOMMARYON T CLARKE KG WAGMAN LD
Citation: Tm. Mccarty et al., SURGICAL-MANAGEMENT OF THYROID-CANCER INVADING THE AIRWAY, Annals of surgical oncology, 4(5), 1997, pp. 403-408
HIGH-DOSE CHEMOTHERAPY AND STEM-CELL RESCUE IN THE TREATMENT OF HIGH-RISK BREAST-CANCER - PROGNOSTIC INDICATORS OF PROGRESSION-FREE AND OVERALL SURVIVAL
Authors: SOMLO G DOROSHOW JH FORMAN SJ ODOMMARYON T LEE J CHOW W HAMASAKI V LEONG L MORGAN R MARGOLIN K RASCHKO J SHIBATA S TETEF M YEN Y SIMPSON J MOLINA A
Citation: G. Somlo et al., HIGH-DOSE CHEMOTHERAPY AND STEM-CELL RESCUE IN THE TREATMENT OF HIGH-RISK BREAST-CANCER - PROGNOSTIC INDICATORS OF PROGRESSION-FREE AND OVERALL SURVIVAL, Journal of clinical oncology, 15(8), 1997, pp. 2882-2893
PHASE-I RADIOIMMUNOTHERAPY TRIAL EVALUATING (90)YTTRIUM LABELED ANTI-CEA CHIMERIC T84.66 IN PATIENTS WITH METASTATIC CEA-PRODUCING MALIGNANCIES
Authors: WONG J CHU D YAMAUCHI D ODOMMARYON T WILLIAMS L LIU A WILCYZNSKI S WU A SHIVELY J DOROSHOW J RAUBITSCHEK A
Citation: J. Wong et al., PHASE-I RADIOIMMUNOTHERAPY TRIAL EVALUATING (90)YTTRIUM LABELED ANTI-CEA CHIMERIC T84.66 IN PATIENTS WITH METASTATIC CEA-PRODUCING MALIGNANCIES, International journal of radiation oncology, biology, physics, 39(2), 1997, pp. 205-205
AMPLIFICATION OF CCND1 AND EXPRESSION OF ITS PROTEIN PRODUCT - CYCLIND1 IN DUCTAL CARCINOMA IN-SITU OF THE BREAST
Authors: SIMPSON JF QUAN DE OMALLEY F ODOMMARYON T CLARKE PE
Citation: Jf. Simpson et al., AMPLIFICATION OF CCND1 AND EXPRESSION OF ITS PROTEIN PRODUCT - CYCLIND1 IN DUCTAL CARCINOMA IN-SITU OF THE BREAST, Laboratory investigation, 76(1), 1997, pp. 131-131
HUMAN PAPILLOMAVIRUS (HPV) IN HEAD AND NECK-CANCER - AN ASSOCIATION OF HPV 16 WITH SQUAMOUS-CELL CARCINOMA OF WALDEYERS TONSILLAR RING
Authors: PAZ IB COOK N ODOMMARYON T XIE Y WILCZYNSKI SP
Citation: Ib. Paz et al., HUMAN PAPILLOMAVIRUS (HPV) IN HEAD AND NECK-CANCER - AN ASSOCIATION OF HPV 16 WITH SQUAMOUS-CELL CARCINOMA OF WALDEYERS TONSILLAR RING, Cancer, 79(3), 1997, pp. 595-604
EFFECT OF CD34(-CELL REINFUSION AND GRANULOCYTE-COLONY-STIMULATING FACTOR PRIMING ON HEMATOPOIETIC RECOVERY AFTER HIGH-DOSE CHEMOTHERAPY FOR BREAST-CANCER() SELECTION AND VARIOUS SCHEDULES OF STEM)
Authors: SOMLO G SNIECINSKI I ODOMMARYON T NOWICKI B CHOW W HAMASAKI V LEONG L MARGOLIN K MORGAN R RASCHKO J SHIBATA S TETEF M MOLINA A BERENSON RJ FORMAN SJ DOROSHOW JH
Citation: G. Somlo et al., EFFECT OF CD34(-CELL REINFUSION AND GRANULOCYTE-COLONY-STIMULATING FACTOR PRIMING ON HEMATOPOIETIC RECOVERY AFTER HIGH-DOSE CHEMOTHERAPY FOR BREAST-CANCER() SELECTION AND VARIOUS SCHEDULES OF STEM), Blood, 89(5), 1997, pp. 1521-1528
AMPLIFICATION OF CCND1 AND EXPRESSION OF ITS PROTEIN PRODUCT, CYCLIN D1, IN DUCTAL CARCINOMA IN-SITU OF THE BREAST
Authors: SIMPSON JF QUAN DE OMALLEY F ODOMMARYON T CLARKE PE
Citation: Jf. Simpson et al., AMPLIFICATION OF CCND1 AND EXPRESSION OF ITS PROTEIN PRODUCT, CYCLIN D1, IN DUCTAL CARCINOMA IN-SITU OF THE BREAST, The American journal of pathology, 151(1), 1997, pp. 161-168
SURVEY OF PHYSICIANS ATTITUDES RELATIVE TO THE FIELD OF SURGICAL ONCOLOGY
Authors: ELLENHORN JDI WAGMAN LD PAZ IB CHU DZJ WILLIAMS WL ODOMMARYON T
Citation: Jdi. Ellenhorn et al., SURVEY OF PHYSICIANS ATTITUDES RELATIVE TO THE FIELD OF SURGICAL ONCOLOGY, Annals of surgical oncology, 3(4), 1996, pp. 406-410
ESTIMATION OF A COMMON ODDS RATIO UNDER BINARY CLUSTER SAMPLING
Authors: AHN C ODOMMARYON T
Citation: C. Ahn et T. Odommaryon, ESTIMATION OF A COMMON ODDS RATIO UNDER BINARY CLUSTER SAMPLING, Statistics in medicine, 14(14), 1995, pp. 1567-1576
FIGURES OF MERIT (FOMS) FOR IMAGING AND THERAPY USING MONOCLONAL-ANTIBODIES
Authors: WILLIAMS LE LIU A WU AM ODOMMARYON T CHAI A RAUBITSCHEK AA WONG JYC
Citation: Le. Williams et al., FIGURES OF MERIT (FOMS) FOR IMAGING AND THERAPY USING MONOCLONAL-ANTIBODIES, Medical physics, 22(12), 1995, pp. 2025-2027
INITIAL EXPERIENCE EVALUATING (90)YTTRIUM-RADIOLABELED ANTICARCINOEMBRYONIC ANTIGEN CHIMERIC T84.66 IN A PHASE-I RADIOIMMUNOTHERAPY TRIAL
Authors: WONG JYC WILLIAMS LE YAMAUCHI DM ODOMMARYON T ESTEBAN JM NEUMAIER M WU AM JOHNSON DK PRIMUS FJ SHIVELY JE RAUBITSCHEK AA
Citation: Jyc. Wong et al., INITIAL EXPERIENCE EVALUATING (90)YTTRIUM-RADIOLABELED ANTICARCINOEMBRYONIC ANTIGEN CHIMERIC T84.66 IN A PHASE-I RADIOIMMUNOTHERAPY TRIAL, Cancer research, 55(23), 1995, pp. 5929-5934
BREAST-CONSERVATION THERAPY - LOCAL TUMOR-CONTROL IN PATIENTS WITH PATHOLOGICALLY CLEAR MARGINS WHO RECEIVE 5000 CGY BREAST IRRADIATION WITHOUT LOCAL BOOST
Authors: PEZNER RD WAGMAN LD BENEZRA J ODOMMARYON T
Citation: Rd. Pezner et al., BREAST-CONSERVATION THERAPY - LOCAL TUMOR-CONTROL IN PATIENTS WITH PATHOLOGICALLY CLEAR MARGINS WHO RECEIVE 5000 CGY BREAST IRRADIATION WITHOUT LOCAL BOOST, Breast cancer research and treatment, 32(3), 1994, pp. 261-267
A PRE-THERAPY IMAGING TRIAL OF AN IN-111 ANTI-CEA CHIMERIC MONOCLONAL-ANTIBODY (CT84.66) IN PATIENTS WITH CEA-PRODUCING MALIGNANCIES
Authors: WONG JYC THOMAS GE YAMAUCHI D WILLIAMS LE ODOMMARYON T ESTEBAN JE NEUMAIER M JOHNSON DK PRIMUS FJ SHIVELY JE RAUBITSCHEK AA
Citation: Jyc. Wong et al., A PRE-THERAPY IMAGING TRIAL OF AN IN-111 ANTI-CEA CHIMERIC MONOCLONAL-ANTIBODY (CT84.66) IN PATIENTS WITH CEA-PRODUCING MALIGNANCIES, The Journal of nuclear medicine, 35(5), 1994, pp. 160000234-160000234
Risultati: 1-14 |